RxDoctor Payments Data

Lucinda Sherman

Family · Pataskala, OHNPI 1194488577

Payments from drug & device makers

$1,077in general payments, 2019–2025

Across 50 payments — averaging $21.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$173
  • Stryker$159
  • Pfizer$126
  • Lilly USA, LLC$119
  • Novo Nordisk$103
  • AstraZeneca$58
  • plus $338 from 11 others

What the payments were for

  • Food & beverage$1,077100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,077 in reported general payments places this provider in the 70th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$11,738
Medicare patients
50
Services billed
143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide26$24,108
Omeprazole45$554
Duloxetine Hcl26$435
Atorvastatin Calcium73$415
Trazodone Hcl36$401
Losartan Potassium45$321
Rosuvastatin Calcium15$274
Bupropion XlBupropion Hcl13$271
Levothyroxine Sodium27$268
Gabapentin11$247
Escitalopram Oxalate20$231
Albuterol Sulfate HfaAlbuterol Sulfate23$200
Metformin Hcl24$174
Carvedilol20$167
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine12$152

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$103$24,10826 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,812 family providers in Ohio.

Other family in Pataskala

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →